1. From leflunomide to teriflunomide: drug development and immunosuppressive oral drugs in the treatment of multiple sclerosis;Aly;Curr. Neuropharmacol.,2017
2. Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS population;Andersen;Mult. Scler. Relat. Disord.,2022
3. Freedom to Be altruistic: allowing for risk/knowledge ratios in decisions concerning multiple sclerosis research;Arenson;Open Med.,2011
4. Dimethyl fumarate: a review in relapsing-remitting MS;Blair;Drugs,2019
5. Real-world disease-modifying therapy usage in persons with relapsing-remitting multiple sclerosis: cross-sectional data from the Swiss multiple sclerosis registry;Bossart;Mult. Scler. Relat. Disord.,2022